Kurt H. Kruger is Director at Qualigen Therapeutics, Inc. (QLGN). They have made 3 open-market trades across 1 company since 2020, most recently 2021-08-19.
CIK 0001375881
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $42K since 2020, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.